Get App Open
In App
Lending
Lending
Open App

AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Nov 07, 16:01
9078.70 -98.90 (-1.08%)
Volume
AVERAGE VOLUME
5-Day
765
10-Day
557
30-Day
758
693
  • Prev. Close

    9177.60

  • Open Price

    9200.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Nov 07, 15:54
9077.50 -105.00 (-1.14%)
Volume
AVERAGE VOLUME
5-Day
20,423
10-Day
14,459
30-Day
13,119
15,929
  • Prev. Close

    9182.50

  • Open Price

    9234.00

  • Bid Price (Qty.)

    9077.50 (2)

  • Offer Price (Qty.)

    0.00 (0)

Company Facts - AstraZeneca Pharma

Registered Address

Block N1, 12th Floor,
Manyata Embassy Business Park, , Rachenahalli, Outer Ring Road,
Bengaluru
Karnataka
560045

Tel: 080-67748000
Fax: 080-67748557
Email: comp.secy@astrazeneca.com
Website: http://www.astrazeneca.com/india
Group: AstraZeneca Group

Registrars

Integrated Registry Management Services Pvt. Ltd. #30, Ramana Residency, 4th Cross, Sampige Road, Ma
Bengaluru - 560003
Karnataka

Tel: 080-23460815-818
Fax: 080-23460819
Email: irg@integratedindia.in
Website: https://www.integratedindia.in

Management - AstraZeneca Pharma

NameDesignation
Shilpa Divekar Nirula Chairperson & Independent Director
Bhavana Agrawal Executive Director
Hooi Bien Chuah Non Executive Director
Revathy Ashok Independent Director
NameDesignation
Praveen Rao Akkinepally Managing Director
Sylvia Lorena Varela Ramon Non Executive Director
Jesus Javier Diaz-Ropero Esteso Non Executive Director
Monica Widhani Independent Director
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347